Keywords: BTGm Voraxaze, US launch, Toxic plasma, Renal function, ASD Healthcare

BTG debuts Voraxaze in the USA

Article | 01 May 2012

Print This

The US subsidiary of the UK-based BTG (LSE: BGC) yesterday announced the launch of Voraxaze (glucarpidase) in the USA. Voraxaze, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in